Log In
BCIQ
Print this Print this
 

P2202

  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat diabetes-metabolic syndrome; Treat Type II diabetes
Regulatory Designation
PartnerEli Lilly and Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today